SCHEMBL6173484

SCHEMBL6173484

CC(c1ccnc(C2CCCCC2)c1)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 3/20 0.38
IGF1R P08069 2/20 0.36
LMNA P02545 2/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CHRNA7 P36544 2/20 0.32
TLR8 Q9NR97 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
TRPV1 Q8NER1 1/20 0.31
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30
APH1B Q8WW43 1/20 0.30
NCSTN Q92542 1/20 0.30
APH1A Q96BI3 1/20 0.30
PSENEN Q9NZ42 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175008 0.83 IGF1R (0.39) HRH4IGF1RLMNAMAPK1HTT
SCHEMBL6173577 0.83 IGF1R (0.39) HRH4IGF1RLMNAMAPK1HTT
SCHEMBL6174486 0.82 IGF1R (0.38) HRH4IGF1RLMNAMAPK1HTT
SCHEMBL6177752 0.81 IGF1R (0.37) IGF1RLMNA
SCHEMBL6175142 0.81 IGF1R (0.38) HRH4IGF1RLMNAMAPK1HTT
SCHEMBL6173805 0.81 IGF1R (0.36) IGF1RLMNA
SCHEMBL6172236 0.80 IGF1R (0.39) HRH4IGF1RLMNAMAPK1HTT
SCHEMBL6173894 0.80 IGF1R (0.37) HRH4IGF1RLMNAMAPK1HTT
SCHEMBL6172419 0.80 HRH4 (0.38) HRH4IGF1RLMNAMAPK1HTT
SCHEMBL6175530 0.80 IGF1R (0.37) HRH4IGF1RLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed